Esperion Therapeutics ESPR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's total current assets?
- Esperion Therapeutics (ESPR) reported total current assets of $459.46M in Q1 2026.
- How has Esperion Therapeutics's total current assets changed year-over-year?
- Esperion Therapeutics's total current assets increased by 44.1% year-over-year, from $318.78M to $459.46M.
- What is the long-term trend for Esperion Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Esperion Therapeutics's total current assets has grown at a 6.0% compound annual growth rate (CAGR), from $345.9M to $462.57M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.